Found: 31
Select item for more details and to access through your institution.
An Analysis of Clinical and Pathologic Features, RecurIndex Genomic Profiles, and Survival Outcomes in HER2-Low Breast Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. e1160, doi. 10.1093/oncolo/oyad159
- By:
- Publication type:
- Article
A Survey of Practice Patterns for Clinical Nodal Staging Prior to Neoadjuvant Chemotherapy in Breast Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. e1142, doi. 10.1093/oncolo/oyad156
- By:
- Publication type:
- Article
A Lung Cancer Patient's Passionate Desire for Sexual Healing.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. 1104, doi. 10.1093/oncolo/oyad268
- By:
- Publication type:
- Article
Taxane-Based Chemotherapy Is Effective in Metastatic Appendiceal Adenocarcinoma.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. e1303, doi. 10.1093/oncolo/oyad263
- By:
- Publication type:
- Article
A Randomized Placebo-Controlled Trial of the Anti-Nerve Growth Factor Antibody Tanezumab in Subjects With Cancer Pain Due to Bone Metastasis.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. e1268, doi. 10.1093/oncolo/oyad188
- By:
- Publication type:
- Article
Safety, Tolerability, and Pharmacokinetics of Senaparib, a Novel PARP1/2 Inhibitor, in Chinese Patients With Advanced Solid Tumors: A Phase I Trial.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. e1259, doi. 10.1093/oncolo/oyad163
- By:
- Publication type:
- Article
A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. e1248, doi. 10.1093/oncolo/oyad146
- By:
- Publication type:
- Article
Anlotinib Combined With Toripalimab as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Prospective, Multicenter, Phase II Study.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. e1239, doi. 10.1093/oncolo/oyad169
- By:
- Publication type:
- Article
Stigma and Social Determinants of Health Associated With Fidelity to Guideline-Concordant Therapy in Patients With Breast Cancer Living With and Without HIV in Botswana.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. e1230, doi. 10.1093/oncolo/oyad183
- By:
- Publication type:
- Article
Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia Biomarker.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. e1219, doi. 10.1093/oncolo/oyad218
- By:
- Publication type:
- Article
Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. e1209, doi. 10.1093/oncolo/oyad210
- By:
- Publication type:
- Article
Prognostic Value of ctDNA Detection in Patients With Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy: A Systematic Review and Meta-analysis.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. e1198, doi. 10.1093/oncolo/oyad151
- By:
- Publication type:
- Article
Pre-Diagnosis Pain in Patients With Pancreatic Cancer Signals the Need for Aggressive Symptom Management.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. e1185, doi. 10.1093/oncolo/oyad153
- By:
- Publication type:
- Article
The Impact of COVID-19 on Treatment Practices for Patients With Early Breast Cancer: A Cross-Sectional Study From a Large Cancer Center in Italy.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. e1179, doi. 10.1093/oncolo/oyad255
- By:
- Publication type:
- Article
Evaluation of Male Breast Cancer and the Application of Sentinel Lymph Node Biopsy: A Multicenter Retrospective Study.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. e1170, doi. 10.1093/oncolo/oyad189
- By:
- Publication type:
- Article
Exocrine Pancreatic Insufficiency Induced by Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. 1085, doi. 10.1093/oncolo/oyad150
- By:
- Publication type:
- Article
Incidence and Resolution of Eribulin-Induced Peripheral Neuropathy (IRENE) in Locally Advanced or Metastatic Breast Cancer: Prospective Cohort Study.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. e1152, doi. 10.1093/oncolo/oyad191
- By:
- Publication type:
- Article
Diagnosis, Treatment, and Prognosis of Patients with Primary Familial Gastrointestinal Stromal Tumor: A Case Report and Literature Review.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. e1134, doi. 10.1093/oncolo/oyad168
- By:
- Publication type:
- Article
Promoting Inclusive Cancer Care: Beyond Medical Interpreters.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. e1131, doi. 10.1093/oncolo/oyad290
- By:
- Publication type:
- Article
Three-Week Versus 4-Week Schedule of nab-Paclitaxel in Patients With Metastatic Breast Cancer: A Randomized Phase II Study.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. 1102, doi. 10.1093/oncolo/oyad288
- By:
- Publication type:
- Article
A Rare Presentation of Aggressive Renal Cell Carcinoma and the Utility of Early Molecular Testing in Rapidly Progressing Malignancies: A Case Report.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. 1094, doi. 10.1093/oncolo/oyad280
- By:
- Publication type:
- Article
A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. 1100, doi. 10.1093/oncolo/oyad158
- By:
- Publication type:
- Article
Real-World Outcomes of Latinx Versus Non-Latinx Patients Treated With First-Line Immunotherapy for Metastatic Renal-Cell Carcinoma.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. 1079, doi. 10.1093/oncolo/oyad190
- By:
- Publication type:
- Article
Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. 1072, doi. 10.1093/oncolo/oyad154
- By:
- Publication type:
- Article
Management of Medullary Thyroid Cancer: Patterns of Recurrence and Outcomes of Reoperative Surgery.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. 1064, doi. 10.1093/oncolo/oyad232
- By:
- Publication type:
- Article
Shifting Sociodemographic Characteristics of a Phase I Clinical Trial Population at an NCI-Designated Comprehensive Cancer Center in the Southeast.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. 1055, doi. 10.1093/oncolo/oyad181
- By:
- Publication type:
- Article
Outcomes in Premenopausal Patients with HR+/HER2− Breast Cancer and Lymph Node Micrometastasis Based on the 21-Gene Recurrence Score.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. 1049, doi. 10.1093/oncolo/oyad234
- By:
- Publication type:
- Article
Anti-EGFR Antibodies in the Management of Advanced Colorectal Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. 1034, doi. 10.1093/oncolo/oyad262
- By:
- Publication type:
- Article
Drivers of Emergency Department Use Among Oncology Patients in the Era of Novel Cancer Therapeutics: A Systematic Review.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. 1020, doi. 10.1093/oncolo/oyad161
- By:
- Publication type:
- Article
Surgical De-Escalation in Medullary Thyroid Cancer: A Commentary.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. 1017, doi. 10.1093/oncolo/oyad276
- By:
- Publication type:
- Article
Early Onset Colorectal Cancer: A Hypothesis.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. 1015, doi. 10.1093/oncolo/oyad274
- By:
- Publication type:
- Article